• ABOUT ELITE
    • Overview
    • Our Facility
    • Management & Key Employees
    • Our Board
    • Careers
  • PRODUCTS
  • PIPELINE
    • Generic
    • Branded
  • TECHNOLOGY
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
logo image
HOME | CAREERS | CONTACT | NEWS |
Share
Skip to content
  • About Elite
    • Overview
    • Management & Key Employees
    • Our Board
    • Careers
  • Products
  • Pipeline
    • Generic
    • Branded
  • Technology
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • Investor Relations
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
    • Investor Relations
    • Press Releases
    • Events &
      Presentations
    • SEC Filings
    • Shareholder
      Meeting
    • Governance
      Documents
    • Investor Contacts
    • Email Alerts

Press Releases

 
Select:
Dec 20, 2005
Elite Announces Amendment to Agreement with IntelliPharmaCeutics

Dec 08, 2005
Elite Announces Successful Results On Abuse Resistant Technology For Narcotic Analgesics

Dec 07, 2005
ELITE PHARMACEUTICALS TO PRESENT AT THE NEW YORK SOCIETY OF SECURITY ANALYSTS 8TH ANNUAL HEALTHCARE INDUSTRY CONFERENCE

Nov 15, 2005
ELITE PHARMACEUTICALS REVIEWS BUSINESS DEVELOPMENTS AND PROJECTED CORPORATE MILESTONES

Nov 09, 2005
Elite Pharmaceuticals, Inc. (AMEX: ELI) will hold a telephone conference call

Sep 07, 2005
ELITE PHARMACEUTICAL ANNOUNCES SUCCESSFUL COMPLETION OF BOND REFINANCING

Jul 27, 2005
ELITE PHARMACEUTICALS TO PRESENT AT THE BANC OF AMERICA SECURITIES 2005 SPECIALTY PHARMACEUTICS CONFERENCE

Jun 28, 2005
Elite Pharmaceuticals Announces Agreement for the Development of a Controlled Release Product

Jun 22, 2005
Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product

May 26, 2005
FDA Approves IND for Elite Pharmaceuticals Abuse-Resistant Oxycodone Product

 21   22   23   24   25     26    27   28   29 
 <<   <   >   >> 
  • Site Map   |  Privacy  |  Terms Of Use
Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.
ART™: Abuse-Resistant Technology for a safer healthier you.
Back to top

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window